HEALTHPEAK PROPERTIES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.8 USD | +2.51% |
|
+4.56% | -5.05% |
| 26/04 | IBM Delivers on Two Key Metrics in 'Solid' Q1 Despite Revenue Miss, RBC Says | MT |
| 26/04 | BNP Paribas Adjusts Price Target on Healthpeak Properties to $21 From $19 | MT |
Summary
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- This company will be of major interest to investors in search of a high dividend stock.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- One of the major weak points of the company is its financial situation.
- With an expected P/E ratio at 48.35 and 31.76 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- Based on current prices, the company has particularly high valuation levels.
- Over the past four months, analysts' average price target has been revised downwards significantly.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialized REITs
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -5.05% | 13.23B | A | ||
| +4.62% | 55.76B | A- | ||
| -11.72% | 17.72B | A- | ||
| +1.40% | 7.68B | B | ||
| -17.93% | 5.39B | B- | ||
| +8.62% | 3.28B | C- | ||
| -5.42% | 3.06B | B+ | ||
| -8.15% | 2.73B | C | ||
| +12.61% | 2.73B | C- | ||
| -13.17% | 2.43B | A- |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- DOC Stock
- Ratings Healthpeak Properties, Inc.
